(Q43091608)

English

Phase II study of asparagine-glycine-arginine-human tumor necrosis factor alpha, a selective vascular targeting agent, in previously treated patients with malignant pleural mesothelioma

scientific article published on 20 April 2010

Statements

Phase II study of asparagine-glycine-arginine-human tumor necrosis factor alpha, a selective vascular targeting agent, in previously treated patients with malignant pleural mesothelioma (English)
Giovanni L Ceresoli
Giovanni Citterio
Tommaso M De Pas
Nicoletta Zilembo
Fabio De Vincenzo
Maria Grazia Viganò
Floriana Fontana
Federico Caligaris-Cappio
Antonio Lambiase

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit